Check out the companies making headlines yesterday:

nLIGHT (NASDAQ: LASR): Laser company nLIGHT (NASDAQ: LASR) rose by 5.5% on Tuesday after the market reacted to the company's successful pivot into the high-growth sectors of AI infrastructure and defense modernization, supported by strong financial performance. See our full article here.

Is now the time to buy nLIGHT? Access our full analysis report here, it's free.

Myriad Genetics (NASDAQ: MYGN): Genetic testing company Myriad Genetics (NASDAQ: MYGN) rose by 6.9% on Tuesday after its President and CEO, Samraat Raha, purchased a significant amount of company stock. See our full article here.

Is now the time to buy Myriad Genetics? Access our full analysis report here, it's free.

Vertex Pharmaceuticals (NASDAQ: VRTX): Biotech company Vertex Pharmaceuticals (NASDAQ: VRTX) rose by 8.3% on Tuesday after the company announced positive results from a late-stage trial for its experimental kidney disease drug, povetacicept. See our full article here.

Is now the time to buy Vertex Pharmaceuticals? Access our full analysis report here, it's free.

Nextpower (NASDAQ: NXT): Solar tracker company Nextpower (NASDAQ: NXT) rose by 5.1% on Tuesday after GLJ Research initiated coverage on the company with a buy rating. See our full article here.

Is now the time to buy Nextpower? Access our full analysis report here, it's free.

Teladoc (NYSE: TDOC): Digital medical services platform Teladoc Health (NYSE: TDOC) rose by 4.4% on Tuesday after Deutsche Bank upgraded the stock to Buy from Hold. See our full article here.

Is now the time to buy Teladoc? Access our full analysis report here, it's free.